Elevance Health, Inc. (LON:0HG8)
344.74
+0.75 (0.22%)
At close: Jan 30, 2026
Elevance Health Revenue
In the year 2025, Elevance Health had annual revenue of $197.58B USD with 12.77% growth. Elevance Health had revenue of $49.31B in the quarter ending December 31, 2025, with 9.61% growth.
Revenue
$197.58B
Revenue Growth
+12.77%
P/S Ratio
0.38
Revenue / Employee
$1.90M
Employees
104,200
Market Cap
56.01B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 197.58B | 22.38B | 12.77% |
| Dec 31, 2024 | 175.20B | 5.00B | 2.93% |
| Dec 31, 2023 | 170.21B | 14.55B | 9.35% |
| Dec 31, 2022 | 155.66B | 18.72B | 13.67% |
| Dec 31, 2021 | 136.94B | 16.14B | 13.36% |
| Dec 31, 2020 | 120.81B | 17.67B | 17.13% |
| Dec 31, 2019 | 103.14B | 11.80B | 12.92% |
| Dec 31, 2018 | 91.34B | 2.28B | 2.56% |
| Dec 31, 2017 | 89.06B | 4.87B | 5.78% |
| Dec 31, 2016 | 84.19B | 5.79B | 7.38% |
| Dec 31, 2015 | 78.40B | 5.38B | 7.37% |
| Dec 31, 2014 | 73.02B | 2.83B | 4.03% |
| Dec 31, 2013 | 70.19B | 9.68B | 15.99% |
| Dec 31, 2012 | 60.51B | 648.80M | 1.08% |
| Dec 31, 2011 | 59.87B | 2.12B | 3.68% |
| Dec 31, 2010 | 57.74B | -3.00B | -4.94% |
| Dec 31, 2009 | 60.74B | -839.20M | -1.36% |
| Dec 31, 2008 | 61.58B | 1.42B | 2.37% |
| Dec 31, 2007 | 60.16B | 3.98B | 7.08% |
| Dec 31, 2006 | 56.18B | 12.19B | 27.71% |
| Dec 31, 2005 | 43.99B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Elevance Health News
- 4 days ago - Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain - Seeking Alpha
- 4 days ago - US Health Insurer Elevance Health Issues Soft Outlook, Lower Premium Forecast For 2026 - Benzinga
- 4 days ago - Elevance Health Stock Dives Again. Why Earnings Are Adding to Medicare Pain. - Barrons
- 4 days ago - Elevance Health Reports $547 Million Profit Despite Rising Costs - Forbes
- 4 days ago - Elevance forecasts 2026 profit below estimates on elevated medical costs - Reuters
- 4 days ago - Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook - Business Wire
- 5 days ago - U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs - Seeking Alpha